ArticleEpilepsy & behavior reports2024
Clinical differences between transient epileptic amnesia (TEA) and recurrent transient global amnesia (r-TGA).
Article in Epilepsy & behavior reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Both transient epileptic amnesia (TEA) and transient global amnesia (TGA) are clinically characterized by temporary amnesic symptoms. TEA involves recurring amnesic episodes, while TGA typically manifests as a singular occurrence. TGA rarely occurs repeatedly, known as recurrent TGA (r-TGA), which complicates differentiation, and raises the possibility of overlap between two disorders. Given the effectiveness of suitable antiseizure medications (ASMs) in treating TEA, accurate diagnosis of the initial event is crucial. In this study, We retrospectively analyzed cases of sudden-onset amnesia at Juntendo University Hospital over the past 14 years. Our investigation identified a total of 17 patients with TEA who met the criteria established by Zeman, along with a total of 9 patients with r-TGA meeting Hodges' criteria. Compared to r-TGA, TEA exhibited a higher recurrent rate, shorter symptoms, more additional symptoms, and increased structural abnormalities on head magnetic resonance imaging (MRI), and more abnormalities electroencephalography (EEG). Moreover, individual amnestic episode duration varied in both TEA and r-TGA. Our study reveals that TGA retains key features in recurrent cases and demonstrates distinctions from TEA. Nevertheless, distinguishing between the two conditions based solely on initial episodes remains challenging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.